Perspectives in the treatment of gastric cancer
Dimitrios H Roukos* and Angelos M Kappas
Correspondence *Department of Surgery, Ioannina University School of Medicine, GR-451 10 Ioannina, Greece
Email droukos@cc.uoi.gr
Survival rates for patients with gastric cancer in Japan are considerably higher than reported for US patients. Surgery for gastric cancer is the mainstay of treatment, but the extent of regional lymphadenectomy is under considerable debate. Roukos and Kappas provide insights explaining the reasons for differences in treatment decisions between the US and Japan. The latest data from recent trials are discussed together with neoadjuvant treatment options, which could improve clinical outcomes.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.